US Stock MarketDetailed Quotes

IKT Inhibikase Therapeutics

Watchlist
  • 3.2000
  • +0.0400+1.27%
Close Dec 20 16:00 ET
  • 3.2700
  • +0.0700+2.19%
Post 20:01 ET
215.02MMarket Cap-1.03P/E (TTM)

Inhibikase Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-18.90%-4.88M
-10.71%-5.05M
35.25%-3.87M
-4.23%-18.09M
3.20%-3.44M
25.43%-4.11M
-4.81%-4.57M
-51.80%-5.97M
-21.36%-17.35M
13.17%-3.56M
Net income from continuing operations
-25.74%-5.78M
14.16%-4.96M
-3.84%-4.65M
-5.40%-19.03M
2.36%-4.18M
-2.24%-4.6M
-24.53%-5.78M
3.51%-4.48M
-22.10%-18.05M
15.13%-4.28M
Depreciation and amortization
-0.23%6.57K
-95.87%6.57K
30.24%6.57K
2,538.67%177.4K
30.27%6.57K
291.61%6.58K
--159.2K
--5.04K
--6.72K
--5.04K
Other non cash items
----
----
----
-52.93%31.54K
168.48%14.26K
----
----
----
104.01%67K
---20.82K
Change In working capital
120.64%742.37K
-114.22%-132.03K
144.53%722.62K
37.14%234.76K
-7.15%592.44K
129.66%336.46K
513.42%928.53K
-414.36%-1.62M
109.70%171.18K
-1.85%638.09K
-Change in receivables
--0
--0
--0
-43.24%39.88K
--0
1,191.93%79.6K
-136.41%-15.08K
-139.63%-24.64K
163.79%70.26K
-124.26%-26.04K
-Change in prepaid assets
-34.39%164.05K
-106.10%-53.44K
99.59%-2.32K
156.32%842.42K
78.32%280.45K
-14.42%250.05K
541,297.53%876.74K
-368.16%-564.82K
142.11%328.66K
119.56%157.28K
-Change in payables and accrued expense
7,433.21%580.28K
-213.07%-76.63K
170.41%726.9K
-151.20%-642.89K
-37.50%313.95K
100.54%7.7K
-21.58%67.77K
-279.64%-1.03M
-117.63%-255.93K
-62.70%502.34K
-Change in other current assets
13.54%30.66K
13.48%29.7K
13.35%28.77K
179.64%106.42K
-26.78%27.86K
--27K
--26.17K
--25.38K
--38.06K
--38.06K
-Change in other current liabilities
-16.94%-32.62K
-16.94%-31.66K
-16.95%-30.73K
-1,026.56%-111.07K
-202.51%-29.82K
---27.89K
---27.07K
---26.28K
---9.86K
---9.86K
Cash from discontinued investing activities
Operating cash flow
-18.90%-4.88M
-10.71%-5.05M
35.25%-3.87M
-4.23%-18.09M
3.20%-3.44M
25.43%-4.11M
-4.81%-4.57M
-51.80%-5.97M
-21.36%-17.35M
13.17%-3.56M
Investing cash flow
Cash flow from continuing investing activities
-85.19%2.53M
-0.26%2.54M
43.28%-3.31M
172.83%11.66M
-142.63%-2.12M
181.53%17.06M
6,017.70%2.55M
-5.84M
-16.01M
4.96M
Net PPE purchase and sale
--0
----
----
94.15%-14.24K
--0
--0
----
----
---243.26K
--0
Net investment purchase and sale
-85.19%2.53M
-0.81%2.54M
43.28%-3.31M
174.04%11.67M
-142.63%-2.12M
182.32%17.06M
--2.56M
---5.84M
---15.76M
--4.96M
Cash from discontinued investing activities
Investing cash flow
-85.19%2.53M
-0.26%2.54M
43.28%-3.31M
172.83%11.66M
-142.63%-2.12M
181.53%17.06M
6,017.70%2.55M
---5.84M
---16.01M
--4.96M
Financing cash flow
Cash flow from continuing financing activities
259,834.29%181.95K
9,115.33%3.24M
-95.72%367K
4,204.63%8.41M
-138.1K
70
-35.99K
4,289.61%8.58M
-100.50%-204.77K
0
Net issuance payments of debt
----
----
----
--0
----
----
----
----
-485.20%-248.91K
--0
Net common stock issuance
259,834.29%181.95K
9,030.27%3.21M
-95.37%397.61K
--8.54M
--452
--70
---35.99K
--8.58M
--0
--0
Proceeds from stock option exercised by employees
----
----
----
--0
----
----
----
----
-43.77%44.14K
--0
Net other financing activities
----
----
---30.61K
---138.56K
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
259,834.29%181.95K
9,115.33%3.24M
-95.72%367K
4,204.63%8.41M
---138.1K
--70
---35.99K
4,289.61%8.58M
-100.50%-204.77K
--0
Net cash flow
Beginning cash position
62.01%3.09M
-40.52%2.35M
27.50%9.17M
-82.36%7.19M
157.03%14.86M
-94.09%1.91M
-89.19%3.96M
-82.36%7.19M
192.04%40.75M
-87.11%5.78M
Current changes in cash
-116.77%-2.17M
135.74%733.11K
-110.77%-6.81M
105.89%1.98M
-504.95%-5.7M
149.02%12.96M
53.36%-2.05M
21.91%-3.23M
-225.25%-33.56M
134.34%1.41M
End cash Position
-93.85%913.42K
62.01%3.09M
-40.52%2.35M
27.50%9.17M
27.50%9.17M
157.03%14.86M
-94.09%1.91M
-89.19%3.96M
-82.36%7.19M
-82.36%7.19M
Free cash flow
-18.90%-4.88M
-10.37%-5.05M
35.25%-3.87M
-2.87%-18.1M
3.20%-3.44M
28.04%-4.11M
-4.11%-4.58M
-51.80%-5.97M
-23.06%-17.59M
13.17%-3.56M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -18.90%-4.88M-10.71%-5.05M35.25%-3.87M-4.23%-18.09M3.20%-3.44M25.43%-4.11M-4.81%-4.57M-51.80%-5.97M-21.36%-17.35M13.17%-3.56M
Net income from continuing operations -25.74%-5.78M14.16%-4.96M-3.84%-4.65M-5.40%-19.03M2.36%-4.18M-2.24%-4.6M-24.53%-5.78M3.51%-4.48M-22.10%-18.05M15.13%-4.28M
Depreciation and amortization -0.23%6.57K-95.87%6.57K30.24%6.57K2,538.67%177.4K30.27%6.57K291.61%6.58K--159.2K--5.04K--6.72K--5.04K
Other non cash items -------------52.93%31.54K168.48%14.26K------------104.01%67K---20.82K
Change In working capital 120.64%742.37K-114.22%-132.03K144.53%722.62K37.14%234.76K-7.15%592.44K129.66%336.46K513.42%928.53K-414.36%-1.62M109.70%171.18K-1.85%638.09K
-Change in receivables --0--0--0-43.24%39.88K--01,191.93%79.6K-136.41%-15.08K-139.63%-24.64K163.79%70.26K-124.26%-26.04K
-Change in prepaid assets -34.39%164.05K-106.10%-53.44K99.59%-2.32K156.32%842.42K78.32%280.45K-14.42%250.05K541,297.53%876.74K-368.16%-564.82K142.11%328.66K119.56%157.28K
-Change in payables and accrued expense 7,433.21%580.28K-213.07%-76.63K170.41%726.9K-151.20%-642.89K-37.50%313.95K100.54%7.7K-21.58%67.77K-279.64%-1.03M-117.63%-255.93K-62.70%502.34K
-Change in other current assets 13.54%30.66K13.48%29.7K13.35%28.77K179.64%106.42K-26.78%27.86K--27K--26.17K--25.38K--38.06K--38.06K
-Change in other current liabilities -16.94%-32.62K-16.94%-31.66K-16.95%-30.73K-1,026.56%-111.07K-202.51%-29.82K---27.89K---27.07K---26.28K---9.86K---9.86K
Cash from discontinued investing activities
Operating cash flow -18.90%-4.88M-10.71%-5.05M35.25%-3.87M-4.23%-18.09M3.20%-3.44M25.43%-4.11M-4.81%-4.57M-51.80%-5.97M-21.36%-17.35M13.17%-3.56M
Investing cash flow
Cash flow from continuing investing activities -85.19%2.53M-0.26%2.54M43.28%-3.31M172.83%11.66M-142.63%-2.12M181.53%17.06M6,017.70%2.55M-5.84M-16.01M4.96M
Net PPE purchase and sale --0--------94.15%-14.24K--0--0-----------243.26K--0
Net investment purchase and sale -85.19%2.53M-0.81%2.54M43.28%-3.31M174.04%11.67M-142.63%-2.12M182.32%17.06M--2.56M---5.84M---15.76M--4.96M
Cash from discontinued investing activities
Investing cash flow -85.19%2.53M-0.26%2.54M43.28%-3.31M172.83%11.66M-142.63%-2.12M181.53%17.06M6,017.70%2.55M---5.84M---16.01M--4.96M
Financing cash flow
Cash flow from continuing financing activities 259,834.29%181.95K9,115.33%3.24M-95.72%367K4,204.63%8.41M-138.1K70-35.99K4,289.61%8.58M-100.50%-204.77K0
Net issuance payments of debt --------------0-----------------485.20%-248.91K--0
Net common stock issuance 259,834.29%181.95K9,030.27%3.21M-95.37%397.61K--8.54M--452--70---35.99K--8.58M--0--0
Proceeds from stock option exercised by employees --------------0-----------------43.77%44.14K--0
Net other financing activities -----------30.61K---138.56K------------------------
Cash from discontinued financing activities
Financing cash flow 259,834.29%181.95K9,115.33%3.24M-95.72%367K4,204.63%8.41M---138.1K--70---35.99K4,289.61%8.58M-100.50%-204.77K--0
Net cash flow
Beginning cash position 62.01%3.09M-40.52%2.35M27.50%9.17M-82.36%7.19M157.03%14.86M-94.09%1.91M-89.19%3.96M-82.36%7.19M192.04%40.75M-87.11%5.78M
Current changes in cash -116.77%-2.17M135.74%733.11K-110.77%-6.81M105.89%1.98M-504.95%-5.7M149.02%12.96M53.36%-2.05M21.91%-3.23M-225.25%-33.56M134.34%1.41M
End cash Position -93.85%913.42K62.01%3.09M-40.52%2.35M27.50%9.17M27.50%9.17M157.03%14.86M-94.09%1.91M-89.19%3.96M-82.36%7.19M-82.36%7.19M
Free cash flow -18.90%-4.88M-10.37%-5.05M35.25%-3.87M-2.87%-18.1M3.20%-3.44M28.04%-4.11M-4.11%-4.58M-51.80%-5.97M-23.06%-17.59M13.17%-3.56M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Micron Technology
MU
+3.48%
NVIDIA
NVDA
+3.08%
Intel
INTC
+2.41%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%

Unlock the Full List